FDX
53
-2
BK
74
-5
JCI
51
-6
CSCO
60
-4
PWR
62
-9
NKE
43
-6
PLD
48
-2
MAS
60
-2
BF.B
59
-2
CVS
39
-11
R
73
-7
TJX
66
11
VRSK
23
-2
CNX
52
-8
ISRG
63
-3
XOM
50
-3
AIV
41
-2
EXPD
37
-5
FMC
16
-13
FTI
82
-2
FDX
53
-2
BK
74
-5
JCI
51
-6
CSCO
60
-4
PWR
62
-9
NKE
43
-6
PLD
48
-2
MAS
60
-2
BF.B
59
-2
CVS
39
-11
R
73
-7
TJX
66
11
VRSK
23
-2
CNX
52
-8
ISRG
63
-3
XOM
50
-3
AIV
41
-2
EXPD
37
-5
FMC
16
-13
FTI
82
-2
Financhill
Back

Altisource Portfolio Solutions SA Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
8

ASPS
Altisource Portfolio Solutions SA

Last Price:
$6.50
Seasonality Move:
-5.17%
Sell
39

MNPR
Monopar Therapeutics, Inc.

Last Price:
$74.46
Seasonality Move:
36.18%
Sell
8
Altisource Portfolio Solutions SA (ASPS) is a Sell

Is Altisource Portfolio Solutions SA a Buy, Sell or Hold?

  • The current Altisource Portfolio Solutions SA [ASPS] share price is $6.59. The Score for ASPS is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • ASPS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $74.61. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ASPS Stock Price Chart

What is Altisource Portfolio Solutions SA's stock price today?

  • The Altisource Portfolio Solutions SA share price today is $6.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASPS is experiencing slight buying pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $74.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.

ASPS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.83 Sell
Relative Strength Index (14 RSI): 26.17 Sell
Chaikin Money Flow: 6732 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.82 - 9.84) Sell
Bollinger Bands (100): (9.16 - 12.04) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.71 Sell
Relative Strength Index (14 RSI): 41.23 Sell
Chaikin Money Flow: -100149 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.75 - 86.63) Sell
Bollinger Bands (100): (43.73 - 88.49) Buy

ASPS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.67 Sell
20-day SMA: 8.59 Sell
50-day SMA: 10.05 Sell
200-day SMA: 9.22 Sell
8-day EMA: 7.44 Sell
20-day EMA: 8.35 Sell
50-day EMA: 9.44 Sell
200-day EMA: 9.89 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.35 Sell
20-day SMA: 81.26 Sell
50-day SMA: 84.43 Sell
200-day SMA: 51.38 Buy
8-day EMA: 77.66 Sell
20-day EMA: 80.1 Sell
50-day EMA: 78.38 Sell
200-day EMA: 56.01 Buy

Altisource Portfolio Solutions SA Earnings Growth & ASPS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Altisource Portfolio Solutions SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):